JOCELYN VIEIRA: Open Payments
NPI 1962015974 · BEVERLY HILLS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$611 in 24 payments from 11 companies in 2025. Trend: 2023 $686 · 2024 $866 · 2025 $611
Food & beverage: $611
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 1 | $120 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 5 | $110 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $84 |
| Lilly USA, LLC | 3 | $56 |
| AstraZeneca Pharmaceuticals LP | 3 | $49 |
| Amgen Inc. | 3 | $43 |
| Esperion Therapeutics, Inc. | 2 | $38 |
| Novo Nordisk Inc | 1 | $34 |
| Alnylam Pharmaceuticals Inc. | 1 | $30 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $28 |
Products named: LifeVest, JARDIANCE, MOUNJARO, REPATHA, NEXLETOL, Wegovy, AMVUTTRA, BRILINTA.
Industry payments across MI — which companies pay providers there.
